资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context

ORIGINAL RESEARCH ARTICLE. 2020-05;

Pascal Mertens1†, Nathalie De Vos2†, Delphine Martiny3, Christian Jassoy4, Ali Mirazimi5, Lize Cuypers6,7, Sigi Van den Wijngaert3, Vanessa Monteil5, Pierrette Melin8, Karolien Stoffels3, Nicolas Yin3, Davide Mileto9, Sabrina Delaunoy3, Henri Magein1, Katrien Lagrou6,7, Justine Bouzet1, Gabriela Serrano3,10, Magali Wautier3, Thierry Leclipteux1, Marc Van Ranst6,7‡, Olivier Vandenberg10,11*‡

Products/Services Used	Details	Operation
Insect Expression	… As mentioned in the audio interview of the New England Journal of Medicine on the 19th of March 2020 (2), the importance of … recNP-2) has been produced in insect cells and purified (2-step purification), with a final purity > 90% (Genscript, Leiden, NL … COVID-19 Ag Respi-Strip …	Get A Quote

摘要

COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to identify positive COVID-19 patients allowing prompt clinical and quarantine decisions. In this original research article, we describe the conception, the analytical and clinical performances as well as the risk management of implementing the COVID-19 Ag Respi-Strip in a diagnostic decision algorithm.